Public Health Implications of Antiretroviral Therapy and HIV Drug Resistance

Widespread use of antiretroviral agents and increasing occurrence of human immunodeficiency virus (HIV) strains resistant to these drugs have given rise to a number of important issues. Some of these concerns are distinct from the obvious question of the relationship between drug resistance and treatment failure and have potentially widespread public health implications. The relevant issues include but are not limited to the following: (1) frequency with which drug-resistant virus may be transmitted via sexual, intravenous, or mother-to-child routes; (2) ability of drug-resistant variants to be transmitted, a question that relates, in part, to the relative fitness of such strains; (3) effectiveness of antiviral therapy in diminishing viral burden in both blood and genital secretions, and whether this may be compromised in persons harboring resistant virus; and (4) importance of patient adherence to antiviral therapy and its relationship to sustained reduction in viral load to minimize the appearance in and transmission of drug-resistant virus from both blood and genital secretions. Thus, prevention of both development of HIV drug resistance as well as transmission of drug-resistant variants is a central issue of public health importance. Unless this topic is appropriately addressed, the likelihood is that drug-resistant variants of HIV, if able to successfully replicate, will sustain the epidemic and limit the effectiveness of antiviral therapy.

Antiretroviral therapy · Antiviral drug · Biology · Drug · Drug resistance · HIV drug resistance · Human immunodeficiency virus (HIV) · Intensive care medicine · Microbicide · Pathology · Pharmacotherapy · Public health · Sexual transmission · Transmission (telecommunications) · Viral load · Virus · Genetics · HIV Research and Treatment · HIV/AIDS drug development and treatment · HIV/AIDS Research and Interventions · Immunology · Internal Medicine · Medicine · Pharmacology · Virology

• Compliance/Adherence, HIV, and the Critique of Medical Power

  Open Access•Eric Mykhalovskiy, Liza Mccoy et al.•Social Theory & Health•2004

  Incluir item

• Ethical and Regulatory Issues Surrounding African Traditional Medicine in the Context of Hiv/Aids

  Open Access•ACEME NYIKA•Developing World Bioethics•2007

  Incluir item

• More Hands in Complex ART Delivery? Experiences from the Expert Clients Initiative in Rural Uganda

  Open Access•Margaret Kyakuwa•African Sociological Review /…•2009

  Incluir item

• An examination of HIV/Aids patients who have excellent adherence to Haart

  S E Malcolm, J Ng et al.•AIDS Care•2003

  Incluir item

• Desenvolvimento de uma escala de auto-eficácia para adesão ao tratamento anti-retroviral

  Open Access•José Carlos De Carvalho Leite, Maria De Lourdes Drachler et al.•Psicologia Reflexão e Crítica•2002

  Incluir item

• Highly Active Antiretroviral Therapy and Sexual Risk Behavior

  Nicole Crepaz, Trevor A Hart et al.•JAMA•2004

  Incluir item

• Accessing Antiretroviral Therapy Following Release From Prison

  Jacques Baillargeon•JAMA•2009

  Incluir item

• Patient adherence to HIV medication regimens

  Open Access•Laurel Fogarty, Linda Fogarty et al.•Patient Education and Counseling•2002

  Incluir item

• Problem drinking and medication adherence among persons with HIV infection

  Robert L Cook, Susan M Sereika et al.•Journal of General Internal…•2001

  Incluir item

• Abuse and Resilience in Relation to Haart Medication Adherence and HIV Viral Load Among Women with HIV in the United States

  Sannisha K Dale, Sannisha Dale et al.•AIDS Patient Care and STDs•2014

  Incluir item

• Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population

  David R Bangsberg, FREDERICK HECHT et al.•AIDS•2000

  Incluir item

• Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users

  Open Access•Mônica Malta, Steffanie A Strathdee et al.•Addiction•2008

  Incluir item

• An information-motivation-behavioral skills model of adherence to antiretroviral therapy.

  Jeffrey D Fisher, William A Fisher et al.•Health Psychology•2006

  Incluir item

• Medication adherence among HIV+ adults

  Open Access•Charles H Hinkin, S A Castellon et al.•Neurology•2002

  Incluir item

• Adherence to Antiretroviral Therapy Among HIV-Infected Drug Users

  Open Access•Mônica Malta, Monica M F Magnanini et al.•AIDS and Behavior•2010

  Incluir item

• Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV Infection

  Open Access•David L Paterson, Susan Swindells et al.•Annals of Internal Medicine•2000

  Incluir item

• Prescription of and Adherence to Antiretroviral Therapy Among Women with Aids

  Open Access•Paula Schuman, Suzanne E Ohmit et al.•AIDS and Behavior•2001

  Incluir item

• Recruitment in Aids Clinical Trials

  Open Access•Kathleen A Ethier, Michael R Rodriguez et al.•AIDS and Behavior•1999

  Incluir item

• Measuring Adherence Among HIV-Infected Persons

  Open Access•Jeffrey H Samet, Lisa M Sullivan et al.•AIDS and Behavior•2001

  Incluir item

• Other-Sensitive Motivation for Safer Sex Among Gay Men

  Open Access•David Nimmons, Susan Folkman•AIDS and Behavior•1999

  Incluir item

• A Qualitative Investigation of Antiretroviral Therapy Among Injection Drug Users

  Open Access•Alfred Pach, FELICIA GRAY CERBONE et al.•AIDS and Behavior•2003

  Incluir item

• Protocol of the randomized control trial

  Open Access•Gabriella Flynn, Haomiao Jia et al.•BMC Public Health•2020

  Incluir item

• Aids Exceptionalism

  Open Access•William A Fisher, Taylor Kohut et al.•Social Issues and Policy Review•2009

  Incluir item

• HIV and the Cycle of Trauma in Gay Men

  James Cassese•Journal of Gay & Lesbian Social…•2000

  Incluir item

• A Mediation Model to Explain HIV Antiretroviral Adherence Among Gay and Bisexual Men

  Perry N Halkitis, Joseph J Palamar et al.•Journal of Gay & Lesbian Social…•2007

  Incluir item

• Risk management in HIV/Aids

  Richard Chawana, D Knapp van Bogaert•African Journal of AIDS Research•2011

  Incluir item

• NGO-provided free HIV treatment and services in Burkina Faso

  Open Access•Valery Ridde, Paul Somé et al.•International Journal for Equity…•2012

  Incluir item

• Mechanisms of Motivational Interviewing for Antiretroviral Medication Adherence in People with HIV

  Open Access•Ailbhe Hogan, Delwyn Catley et al.•AIDS and Behavior•2020

  Incluir item

• Cognitive Executive Functioning in Relation to HIV Medication Adherence Among Gay, Bisexual, and other Men who have Sex with Men

  Open Access•Todd M Solomon, Perry N Halkitis•AIDS and Behavior•2007

  Incluir item

• Prospective Study of Attitudinal and Relationship Predictors of Sexual Risk in the Multicenter Aids Cohort Study

  Open Access•David G Ostrow, Michael J Silverberg et al.•AIDS and Behavior•2007

  Incluir item

• Changes in Substance Use Symptoms Across Adolescence in Youth Perinatally Infected with HIV

  Open Access•Massy Mutumba, Katherine S Elkington et al.•AIDS and Behavior•2016

  Incluir item

• Neurocognitive Aspects of Medication Adherence in HIV-Positive Injecting Drug Users

  Open Access•Drenna Waldrop-Valverde, Drenna Waldrop‐Valverde et al.•AIDS and Behavior•2006

  Incluir item

• Medication Beliefs as Mediators of the Health Literacy–Antiretroviral Adherence Relationship in HIV-infected Individuals

  Open Access•Joseph Graham, Ian M Bennett et al.•AIDS and Behavior•2006

  Incluir item

• Adherence Study

  Open Access•Marcia Sampaio-Sa, Kimberly Page et al.•AIDS and Behavior•2008

  Incluir item

• Community-based DOT-Haart Accompaniment in an Urban Resource-Poor Setting

  Open Access•Maribel Muñoz, Karen E Finnegan et al.•AIDS and Behavior•2009

  Incluir item

• Drug Use and Medication Adherence among HIV-1 Infected Individuals

  Open Access•Charles H Hinkin, Terry R Barclay et al.•AIDS and Behavior•2006

  Incluir item

• Preparing for highly active antiretroviral therapy rollout in rural South Africa

  Margo D Simon, Margo Simon et al.•AIDS Care•2010

  Incluir item

• How late is too late? Timeliness to scheduled visits as an antiretroviral therapy adherence measure in Nairobi, Kenya and Lusaka, Zambia

  Rachel J Blacher, Rachel Blacher et al.•AIDS Care•2010

  Incluir item

• The mysteries and demands of HIV care

  Barbara Gerbert, Nona Caspers et al.•AIDS Care•2004

  Incluir item

• Posttraumatic stress disorder symptoms, salivary cortisol, medication adherence, and CD4 levels in HIV-positive individuals

  Douglas L Delahanty, Laura M Bogart et al.•AIDS Care•2004

  Incluir item

• Methamphetamine abuse as a barrier to HIV medication adherence among gay and bisexual men

  Cathy J Reback, Sherry Larkins et al.•AIDS Care•2003

  Incluir item

• ART adherence, demographic variables and CD4 outcome among HIV-positive patients on antiretroviral therapy in Chennai, India

  Steven A Safren, N Kumarasamy et al.•AIDS Care•2005

  Incluir item

• Physician and patient prediction of adherence to antiretroviral therapy in HIV positive people in Saint-Petersburg, Russia

  Marina V Vetrova, Olga Aleksandrova et al.•AIDS Care•2021

  Incluir item

• Barriers to acceptance and adherence of antiretroviral therapy in urban Zambian women

  Laura K Murray, Laura Murray et al.•AIDS Care•2009

  Incluir item

• The impact of specific HIV treatment-related adverse events on adherence to antiretroviral therapy

  Imad Al-Dakkak, Seema Patel et al.•AIDS Care•2013

  Incluir item

• Adherence to Haart

  Sigrid C J M Vervoort, Mieke Grypdonck et al.•AIDS Care•2009

  Incluir item

• Quality of life and adherence to antiretroviral therapy in Southern Brazil

  Carlos Zubaran, Gregory Medeiros et al.•AIDS Care•2014

  Incluir item

• Use of an on-line pager system to increase adherence to antiretroviral medications

  Steven A Safren, Ellen Hendriksen et al.•AIDS Care•2003

  Incluir item

• Barriers to antiretroviral treatment access for injecting drug users living with HIV in Chennai, South India

  Venkatesan Chakrapani, Jaikumar Velayudham et al.•AIDS Care•2014

  Incluir item

• Adherence to Haart among patients with HIV

  Jeannette R Ickovics, Christina S Meade•AIDS Care•2002

  Incluir item

• Psychosocial burdens negatively impact HIV antiretroviral adherence in gay, bisexual, and other men who have sex with men aged 50 and older

  Perry N Halkitis, Rafael Eduardo Perez-Figueroa et al.•AIDS Care•2014

  Incluir item

• Development of an easy to use tool to assess HIV treatment readiness in adolescent clinical care settings

  M Isabel Fernandez, Sybil Hosek et al.•AIDS Care•2011

  Incluir item

• Community-based follow-up for late patients enrolled in a district-wide programme for antiretroviral therapy in Lusaka, Zambia

  D Krebs, D W Krebs et al.•AIDS Care•2008

  Incluir item

• Psychosocial Factors Predict CD4 and Viral Load Change in Men and Women With Human Immunodeficiency Virus in the Era of Highly Active Antiretroviral Treatment

  Gail Ironson, Conall O’cleirigh et al.•Psychosomatic Medicine•2005

  Incluir item

• Accès aux multithérapies antirétrovirales du Sida

  Pierre Lasserre, Jean-Paul Moatti et al.•Revue économique•2004

  Incluir item

• Highly active antiretroviral treatment does not increase sexual risk behaviour among French HIV infected injecting drug users

  A-D Bouhnik, J P Moatti et al.•Journal of Epidemiology and…•2002

  Incluir item

• Changes in Sexual Behavior Among HIV-Infected Women After Initiation of Haart

  Tracey E Wilson, Mary Elizabeth Gore et al.•American Journal of Public Health•2004

  Incluir item

• Impacto de intervenções no uso de preservativos em portadores do HIV

  Open Access•Mariela Felisbino Da Silveira, Mariângela F Silveira et al.•Revista de Saúde Pública•2005

  Incluir item

• Adherence to and Effectiveness of Highly Active Antiretroviral Treatment for HIV Infection

  Karine Lamiraud, Jean-Paul Moatti et al.•Medical Care•2012

  Incluir item

• Determining the Cost-Savings Threshold for HIV Adherence Intervention Studies for Persons with Serious Mental Illness and HIV

  Open Access•Evan Wu, Evan S Wu et al.•Community Mental Health Journal•2014

  Incluir item

• Barebacking Among Gay and Bisexual Men in New York City

  Open Access•Perry N Halkitis, Jeffrey T Parsons et al.•Archives of Sexual Behavior•2003

  Incluir item

• Negotiating Risks in Context

  Open Access•Troy Suarez, Jeffrey Miller•Archives of Sexual Behavior•2001

  Incluir item

• Protease Inhibitors

  Open Access•Marjorie A Merithew, Loretta Davis-Satterla•Qualitative Health Research•2000

  Incluir item

• The Challenge of HIV for Feminist Theory

  Open Access•M Rosengarten•Feminist Theory•2004

  Incluir item

• Access to highly active antiretroviral therapy for injection drug users

  Open Access•David Vlahov, David D Celentano•Cadernos de Saude Publica•2006

  Incluir item

• Gay Men and HIV/Aids Risk Management

  Open Access•Paul Flowers•Health An Interdisciplinary…•2001

  Incluir item

• Bridging the Gap Between Antiretroviral Access and Adherence in Mexico

  Open Access•Lourdes Campero, Cristina Herrera et al.•Qualitative Health Research•2007

  Incluir item

• Vulnerability, unsafe sex and non-adherence to Haart

  Open Access•Patrick Peretti-Watel, Bruno Spire et al.•Social Science & Medicine•2006

  Incluir item

• The Social Realities of Adherence to Protease Inhibitor Regimens

  Open Access•Perry N Halkitis, Alexandra H Kutnick et al.•Journal of Health Psychology•2005

  Incluir item

• A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less

  Scott M Hammer, Kathleen E Squires et al.•New England Journal of Medicine•1997

  Incluir item

• Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment

  Edward M Connor, Rhoda S Sperling et al.•New England Journal of Medicine•1994

  Incluir item

• Zidovudine adherence among individuals with HIV infection

  Richard D Muma, Michael W Ro et al.•AIDS Care•1995

  Incluir item

• Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus

  N Singh, Cheryl Squier et al.•AIDS Care•1996

  Incluir item